biotech
Ulcerative Colitis Responds to Arthritis Drug Infliximab (Remicade)
Filed in archive Drugs, Vaccines and Therapeutics by ruth on September 19, 2006
Ulcerative Colitis Responds to Arthritis Drug Infliximab (Remicade)
A controlled clinical study involving 860 patients showed that infliximab (brand name: Remicade), a drug currently used to treat rheumatoid arthritis and Crohn's disease, is also effective as an alternative treatment for ulcerative colitis.
"For people with active ulcerative colitis who do not respond to corticosteroids or immunosuppressive agents, infliximab is effective in inducing clinical remission, inducing clinical response, promoting mucosal healing and reducing the need for colectomy, at least in the short term," said review co-author Dr. Anthony Kwaku Akobeng.


Critics say, however that further tests, including a direct comparison of infliximab with cyclosporine, another drug commonly used when other medications fail.

[Image: Endoscopic image of ulcerative colitis affecting the left side of the colon. The image shows confluent superficial ulceration and loss of mucosal architecture. Source: Wikipedia]


Related Entries:

Permalink: Ulcerative Colitis Responds to Arthritis Drug Infliximab (Remicade)
Tags: ulcer  ulcerative+colitis  arthritis  chrons+disease  corticosteroids  remicade  biotech  infliximab+remica 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/36709
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Ulcerative Colitis Responds to Arthritis Drug Infliximab (Remicade):

  • Currently 7.60/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.60 out of 5 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!